ARC Themes
Resource Stage
Status
Health Category
What we are doing?
We are investigating medication adherence measurement techniques, and outcomes of interventions that are intended to improve medication adherence in patients with cardiometabolic diseases. We are focusing on hypertension patients and are also investigating health inequalities in this area.
Why we are doing it?
Medication non-adherence drives waste and elevated healthcare costs, costing an estimated £300 million annually in England. Medication non-adherence is widespread - rates are typically 30-50% in any given 6-month period, and up to 80% in those with multiple long-term conditions (MLTCs).
What the benefits will be and to whom?
Improvements in medication adherence would benefit patients by bringing them closer to intended therapeutic outcomes. Ethnic minority populations are at greater risk of cardiovascular disease and antihypertensive medication non-adherence and would therefore see greater benefit from advances in this area.
Who we are working with?
We are working with colleagues at the University of Leicester and Leicester Diabetes Centre.
Contact
Kassam Hassam, PhD Student, University of Leicester and Leicester Diabetes Centre, kh429@le.ac.uk.